<DOC>
	<DOCNO>NCT00421980</DOCNO>
	<brief_summary>The primary objective study determine long-term safety etanercept adult AS complete study 0881A3-311-EU .</brief_summary>
	<brief_title>An Open-Label , Multicentre , Long-Term Extension Study Etanercept Ankylosing Spondylitis</brief_title>
	<detailed_description>This open-label , multicenter extension study conduct evaluate safety efficacy etanercept treatment adult subject AS complete study 0881A3-311-EU . The study consist open-label treatment period approximately 96 week .</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>1 . Completed entire 12 week therapy study 0881A3311EU , complete least 8 week therapy return week 12 visit study 0881A3311EU . 2 . Negative serum βHCG pregnancy test baseline ( woman childbearing potential ) . 3 . Sexually active woman childbearing potential use medically acceptable form contraception . Medically acceptable form contraception include oral contraceptive , injectable implantable method , intrauterine device , properly use barrier contraception . Additionally , use condom suggest adjunct method previously address protect sexually transmit disease provide additional protection accidental pregnancy . 4 . Sexually active men agree use medically accept form contraception study . 5 . Able reconstitute selfinject test article designee . 6 . Capable understanding willing provide sign dated write voluntary informed consent protocolspecific procedure perform . 7 . Able store injectable test article 2°C 8°C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>